ITGAM and neoplasm: In our mouse model of orthotopic PDAC, we observed that N6L treatment affects the relative abundance of the total myeloid (CD11b+) cells but does not significantly change the proportion of the tumour-associated macrophages (TAMs) (CD11b+/F4/80+); neither M1 or M2 polarized TAMs.